Finance

Lists
87E:FRA
Dianthus Therapeutics Inc
€92.00
+0.55%
(+0.50) 1D
Sep 11, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 87E...
Open
€88.50
High
€92.00
Low
€88.50
Mkt. cap
5.94B
Avg. vol.
0.00
Volume
100.00
52-wk high
€99.50
52-wk low
€28.40
No. of employees
92
Open
€88.50
High
€92.00
Low
€88.50
Mkt. cap
5.94B
Avg. vol.
0.00
Volume
100.00
52-wk high
€99.50
52-wk low
€28.40
No. of employees
92
News stories
From web sources and news partners
About Dianthus Therapeutics Inc
CEO-
Employees92
Founded2019
Headquarters-
SectorBiotechnology
Websitedianthustx.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
396.00K
284.00K
463.00K
761.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
32.49M
59.92M
34.53M
48.69M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.20M
9.91M
12.47M
13.56M
Operating expense
40.68M
69.82M
47.00M
62.24M
Total operating expenses
40.68M
69.82M
47.00M
62.24M
Operating income
-40.29M
-69.54M
-46.53M
-61.48M
Other non operating income
-360.00K
-409.00K
-249.00K
-370.00K
EBT including unusual items
-36.76M
-64.43M
-40.83M
-50.22M
EBT excluding unusual items
-39.30M
-65.54M
-41.75M
-55.97M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-36.76M
-64.43M
-40.83M
-50.22M
Net profit margin
-9,284.09%
-22,687.32%
-8,819.44%
-6,598.55%
Earnings per share
-0.97
-1.43
-0.85
-0.90
Interest and investment income
1.35M
4.41M
5.05M
5.89M
Interest expense
-
-
-
-
Net interest expenses
1.35M
4.41M
5.05M
5.89M
Depreciation and amortization charges
-
-
-
-
EBITDA
-40.26M
-69.51M
-46.50M
-61.44M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps